Summary:
- This article discusses new research on how the BRCA2 and FIGNL1 genes are involved in chemoresistance, which is the ability of cancer cells to resist chemotherapy treatments.
- The research suggests that targeting these genes could help overcome chemoresistance and make cancer treatments more effective.
- Understanding the molecular mechanisms behind chemoresistance is an important step in developing better cancer therapies and improving patient outcomes.